Long-term management of scalp psoriasis: perspectives from the international psoriasis council

References

• Kaur I, Handa S, Kumar B. Natural history of psoriasis: a study from the Indian subcontinent. J Dermatol. 1997;24:230–234.
   PubMedGoogle Scholar
• Wozel G. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas. Clin Dermatol. 2008;26:448–459.
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol. 2007;156:258–262.
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC, de Hoop D, de Korte J, Kuipers MV. Scalp psoriasis, clinical presentations and therapeutic management. Dermatology. 1998;197:326–334.
   PubMed Web of Science ®Google Scholar
• Poulin Y, Papp K, Bissonnette R, Guenther L, Tan J, Lynde C, et al. Clobetasol propionate shampoo 0.05% is efficaceous and safe for long-term control of scalp psoriasis. Cutis. 2010;85:43–50.
   PubMedGoogle Scholar
• Barnes L, Altmeyer P, Forstrom L, et al. Long-term treatment of psoriasis with psoriasis scalp solution and cream. Eur J Dermatol. 2000;10:199–204.
   PubMed Web of Science ®Google Scholar
• Jemec BBE, Ganslandt C, Ortonne JP, et al. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized double-blind, controlled study. J Am Acad Dermatol. 2008;59:455–463.
   PubMed Web of Science ®Google Scholar
• Van de Kerkhof PCM, Hoffmann V, Anstey A, et al. A new scalp formulation of calcipotriol plus betamthasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind controlled trial. Br J Dermatol. 2009;160:170–176.
   PubMed Web of Science ®Google Scholar
• Kragballe K, Hoffmann V, Ortonne JP, et al. Efficacy and safety calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial. Br J Dermatol. 2009;161:159–166.
   PubMed Web of Science ®Google Scholar
• Luger TA, Cambazard F, Larsen FG, et al. A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis. Dermatology. 2008;217:321–328.
   PubMed Web of Science ®Google Scholar
• Chan CS, Van Voorhees AS, Lebwohl MG, et al. Treatment of severe scalp psoriasis from the medical board of the national psoriasis foundation. J Am Acad Dermatol. 2009;60:962–971.
   PubMed Web of Science ®Google Scholar
• Ortonne JP, Chimenti S, Puig L, et al. Scalp Psoriasis: European consensus on grading and treatment algorithm. J Eur Acad Dermatol Venereol. 2009;23:1435–1444.
   PubMed Web of Science ®Google Scholar
• Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137:280–284.
   PubMed Web of Science ®Google Scholar
• Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol. 1997;137:755–760.
   PubMed Web of Science ®Google Scholar
• Chen SC, Yeung J, Chren MM. Scalpdex: a quality-of-life instrument for scalp dermatitis. Arch Dematol. 2002;138:803–807.
   PubMed Web of Science ®Google Scholar
• Baer AH, Khanna V, Feldman SR. Literature is lacking in discussion of non-adherence in dermatology. J Dermatolog Treat. 2010;21:109–110.
   PubMed Web of Science ®Google Scholar
• Augustin M, Holland B, Dartsch D, et al. Adherence in the treatment of psoriasis: a systemic review. Dermatology. 2011;222:363–374.
   PubMed Web of Science ®Google Scholar
• Gokdemir G, Ari S, Köşlö A. Adherence to treatment in patients with psoriasis vulgaris: Turkish experience. J Eur Acad Dermatol Venereol. 2008;22:330–335.
   PubMed Web of Science ®Google Scholar
• Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55:607–613.
   PubMed Web of Science ®Google Scholar
• Storm A, Andersen SE, Benfeldt E, et al. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27–33.
   PubMed Web of Science ®Google Scholar
• Feldman SR, Camacho FT, Krejci-Manwaring J, et al. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57:81–83.
   PubMed Web of Science ®Google Scholar
• Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51:212–216.
   PubMed Web of Science ®Google Scholar
• Bewley A, Page B. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):9–14.
   PubMed Web of Science ®Google Scholar
• van de Kerkhof P, Kragballe K, Segaert S, Lebwohl M. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. J Eur Acad Dermatol Venereol. 2011;25:1130–1139.
   PubMed Web of Science ®Google Scholar
• Feldman SR. Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle. J Drugs Dermatol. 2010;9:908–911.
   PubMed Web of Science ®Google Scholar
• Zivkovich AH, Feldman SR. Are ointments better than other vehicles for corticosteroid treatment of psoriasis? J Drugs Dermatol. 2009;8:570–572.
   PubMed Web of Science ®Google Scholar
• Kurian A, Barankin B. Current effective topical therapies in the management of psoriasis. Skin Therapy Lett. 2011;16:4–7.
   PubMedGoogle Scholar
• Feldman SR, Yentzer BA. Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations. Am J Clin Dermatol. 2009;10:397–406.
   PubMed Web of Science ®Google Scholar
• Mrowietz U, Macheleidt O, Eicke C. Effective treatment and improvement of quality of life in patients with scalp psoriasis by topical use of calcipotriol/betamethasone (Xamiol®) gel: results. J Dtsch Dermatol Ges. 2011;9:825–831.
   PubMed Web of Science ®Google Scholar
• Courtenay M, Carey N, Stenner K, et al. Patients' views of nurse prescribing: effects on care, concordance and medicine taking. Br J Dermatol. 2011;164:396–401.
   PubMed Web of Science ®Google Scholar
• Ersser SJ, Cowdell FC, Nicholls PG. A pilot randomized controlled trial to examine the feasibility and efficacy of an educational nursing intervention to improve self-management practices in patients with mild-moderate psoriasis. J Eur Acad Dermatol Venereol. 2011; [Epub ahead of print].
   PubMedGoogle Scholar
• Pouplard C, Gourraud PA, Meyer N, et al. Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis. Br J Dermatol. 2011;165:1332–1336.
   PubMed Web of Science ®Google Scholar